Copyright © 2019 Fondation Franco Regli. All rights reserved.

The Prize

Eligibility

The award addresses researchers whose excellent work significantly contributes to research in the area of neurodegenerative diseases.

 

All researchers may apply if a significant part of the research described in the publication has been conducted in Switzerland. Swiss researchers may submit work carried out abroad.

 

Both works in basic research and clinical research may be submitted.

 

The publication must be either published or accepted for publication in a peer-reviewed scientific journal.

1/1

Conditions

1/1

The prize is awarded to the main author or the research team, in line with the guidelines of their institution.

 

All co-authors and institutions contributing to the publication may be mentioned by name in the written or verbal appraisal of the awarded research work.

 

The awardee is requested to present their awarded research.

 

The foundation committee may exceptionally decide to award more than one research work for the prize.

 

In case no application qualifies for the prize, the prize may be cancelled or postponed to the following year.

Call for application

Prize Franco Regli 2019

 

The Franco Regli Foundation for Research in the Field of Neurodegenerative Diseases awards a prize of CHF 10’000 to a researcher or a research team working in Switzerland – no matter the nationality – having achieved an outstanding scientific publication in the mentioned area. Swiss authors may submit work carried out abroad.

 

For a publication to be considered, it needs to be published in a peer reviewed scientific journal in 2018/2019 or accepted for publication in 2019.

 

Application deadline is December 31, 2019.

 

Candidates are requested to send their scientific publication along with their CV to the email below. In addition, a hard copy must be sent to the postal address below. If a work is not yet published, but is accepted for publication, please attach the journal’s letter of acceptance.
 

Address: Maria Cristina Donati-Regli, Secretary and Board Member, Brunnadernstrasse 29, 3006 Bern.

Email: info@fondationfrancoregli.ch

Awardees

Franco Regli Prize 2017:

1st Prize: Dr. med Christian Barro, Clinique neurologique et policlinique, Département de médecine, bio-médecine et recherche clinique, Hôpital universitaire de Bâle et Université de Bâle, pour le travail:

 

Disanto G*, Barro C*, Benkert P*, Naegelin Y, Schädelin S, Giardiello A,  Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J,  et the Swiss Multiple Sclerosis Cohort Study Group. Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol, 2017. 81(6):857-870. *equal contribution

2nd Prize: Prof. Dr. med. Caroline Pot and Dr. med. Aurélie Clottu, Département des neurosciences cliniques, Service de neurologie, CHUV, Lausanne

 

Clottu A, Mathias A, Sailer AW, Schluep M, Seebach JD, Du Pasquier R, Pot C, for the work:

EBI2 expression and function: robust in memory lymphocytes and increased by natalizumab in multiple sclerosis. Cell Rep. 2017 Jan 3;18(1):213-224. 

Former awardees:

 

2001

Dr. David Winkler, Department of Neuropathology, Institute of Pathology University of Basel, for the work:

Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, Tolnay M, Staufenbiel M, Jucker M. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloïd angiopathy, J Neuroscience. 2001 Mar 1: 21(5):1619-1627.

2002

Dr. Pierre Burkhard, Département des Neurosciences, HUG, Genève, for the work:

Burkhard P, Delavalle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis, Arch Neurology. 2003; 60: 521-528.

 

PD Dr. Hans H Jung, Neurologische Klinik Universitätspital Zürich, for the work:

Jung HH , Hergersberg M, Vogt M, Pahnke J, Treyer V, Röthlisberger B, Kollias SS, Russo D, Frwey BM. McLeod phenotype associated with a XK missense without hematological, neuromuscular or cerebral involvement. Accepté pour publication dans Journal of Transfusion.

 

Dr. Alexandre Croquelois, Service de neurologie, CHUV, Lausanne, for the work:

Croquelois A, Wintermark M, Reichert M, Meuli R, Bougousslavsky J. Stroke aphasia, the first 6 hours and after: a perfusion-CT and DWI correlation study. Accepté pour publication dans Annals of Neurology.

 

2003

Dr. Fabienne Picard, Département des Neurosciences HUG, Genève, pour le travail :

Picard F, Bertrad D, Le Hellard S, Weiland S, Favre I, Philips H, Bertrand S, Berkovic SF, Malafosse A, Mullery J. How mutations in the nAChRs can cause ADNFLE Epilepsy. Epilepsia. 2002;43 Suppl 5:112-22.

 

2006

PhD Kilic Ertugrul, Neurologische Klinik Universitätspital Zürich, for the work:

Kilic E, Kilic Ü, Wang Y, Bassetti CL, Marti HH, Hermann DM. The phosphatidylinisotol-3 kinase/Akt pathway mediates VEGEF’s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J. 2006 Jun;20(8):1185-7.

 

Dr. Robert H. Andres, Depatment of Neurosurgery, University Hospital Berne, for the work:

Andres RH, Ducray AD, Huber AW, Pérez-Bouza A, Krebs SH, Schlattner U, Seiler RW, Wallimann T, Widmer HR. Effects of creatine treatment on survival and differentiation of GABA-ergic neurons in cultured striatal tissue. Journal of Neurochemistry, Wiley : 2005; 95:33-45.

 

2010

Dr. Florence Clavaguera, Institut für Pathologie Universitätsspital Basel, for the work:

Clavaguera Florence, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M. Transmission and spreading of tauopathy in transgenic mouse brain. Nature Cell Biology : 2009; 11:909-013.

 

PD Dr. méd. Andrea O. Rossetti, Service de neurologie CHUV, Lausanne, for the work:

Rossetti AO, Oddo M, Lagroscino G, Kaplan PW. Prognostication after cardiac arrest hypothermia. A prospective study. Ann Neurol: 2010;67:301-307.

 

2013

Dr. Tiziana Sonati, Dr. Regina M. Reimann, Prof. Dr. Adriano Aguzzi, Institute of Neuropathology, University Hospital Zurich, for the work:

Tiziana Sonati, Regina M Reimann, Jeppe Falsig, Pravas Kumar Baral, Tracy O’Connor, Simone Hornemann, Sine Yaganoglu, Bei Li, Uli S. Herrmann, Barbara Wieland, Mridula Swayampakula, Muhammad Hafizur Rahman, Dipankar Das, Nat Kav, Roland Riek, Pawel P. Liberski, Michael N.G. James & Adriano Aguzzi. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein. Nature: 2013 (5 September); 501(7465):102-6.

 

Dr. Paolo Paganetti, NSI/EOC-Laboratorio sperimentale, Bellinzona et Prof. Dr. Maurizio Molinari, Institute for Research in Biomedicine, Bellinzona, for the work:

Paolo Paganetti, Julia Reichwald, Dorothee Bleckmann, Dorothee Abramowski, Domenico Ammaturo, Carmen Barske, Simone Danner, Maurizio Molinari, Matthias Müller, Stéphane Papin, Sabine Rabe, Peter Schmid, Matthias Staufenbiel. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice. Neurobiology of Aging. 2013; 34(12):2866-78.